Global Immunohematology Market 2021-2025

The publisher has been monitoring the immunohematology market and it is poised to grow by $907.43 mn during 2021-2025, progressing at a CAGR of 7.75% during the forecast period. The report on the immunohematology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for blood banks and its potential to increase sales and paradigm shift of end-users toward automated immunohematology analyzer.

The immunohematology market analysis includes the product segment and geographic landscape.

The immunohematology market is segmented as below:

By Product

Analyzers and systems
Reagents

By Geographical Landscape

North America
Europe
Asia
ROW

This study identifies the increasing sales through service-oriented sales organizations and GPOs as one of the prime reasons driving the immunohematology market growth during the next few years.

The report on immunohematology market covers the following areas:

Immunohematology market sizing
Immunohematology market forecast
Immunohematology market industry analysis

The publisher robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohematology market vendors that include Becton Dickinson and Co., Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Immucor Inc., Merck KGaA, and The Carlyle Group Inc. Also, the immunohematology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market Overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product

Market segments
Comparison by Product
Analyzers and systems - Market size and forecast 2020-2025
Reagents - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape

Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
Becton Dickinson and Co.
Bio Rad Laboratories Inc.
biosurfit SA
Cardinal Health Inc.
Danaher Corp.
DIAGAST SAS
Grifols SA
Immucor Inc.
Merck KGaA
The Carlyle Group Inc.

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

List of Exhibits

Exhibits 1: Key Finding 1
Exhibits 2: Key Finding 2
Exhibits 3: Key Finding 3
Exhibits 4: Key Finding 5
Exhibits 5: Key Finding 6
Exhibits 6: Key Finding 7
Exhibits 7: Key Finding 8
Exhibits 8: Parent market
Exhibits 9: Market characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits 13: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits 14: Five forces analysis 2020 & 2025
Exhibits 15: Bargaining power of buyers
Exhibits 16: Bargaining power of suppliers
Exhibits 17: Threat of new entrants
Exhibits 18: Threat of substitutes
Exhibits 19: Threat of rivalry
Exhibits 20: Market condition - Five forces 2020
Exhibits 21: Product - Market share 2020-2025 (%)
Exhibits 22: Comparison by Product
Exhibits 23: Analyzers and systems - Market size and forecast 2020-2025 ($ million)
Exhibits 24: Analyzers and systems - Year-over-year growth 2020-2025 (%)
Exhibits 25: Reagents - Market size and forecast 2020-2025 ($ million)
Exhibits 26: Reagents - Year-over-year growth 2020-2025 (%)
Exhibits 27: Market opportunity by Product
Exhibits 28: Customer landscape
Exhibits 29: Market share By Geographical Landscape 2020-2025 (%)
Exhibits 30: Geographic comparison
Exhibits 31: North America - Market size and forecast 2020-2025 ($ million)
Exhibits 32: North America - Year-over-year growth 2020-2025 (%)
Exhibits 33: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits 34: Europe - Year-over-year growth 2020-2025 (%)
Exhibits 35: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits 36: Asia - Year-over-year growth 2020-2025 (%)
Exhibits 37: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits 38: ROW - Year-over-year growth 2020-2025 (%)
Exhibits 39: Key leading countries
Exhibits 40: Market opportunity By Geographical Landscape ($ million)
Exhibits 41: Impact of drivers and challenges
Exhibits 42: Vendor landscape
Exhibits 43: Landscape disruption
Exhibits 44: Industry risks
Exhibits 45: Vendors covered
Exhibits 46: Market positioning of vendors
Exhibits 47: Becton Dickinson and Co. - Overview
Exhibits 48: Becton Dickinson and Co. - Business segments
Exhibits 49: Becton Dickinson and Co. - Key offerings
Exhibits 50: Becton Dickinson and Co. - Key customers
Exhibits 51: Becton Dickinson and Co. - Segment focus
Exhibits 52: Bio Rad Laboratories Inc. - Overview
Exhibits 53: Bio Rad Laboratories Inc. - Business segments
Exhibits 54: Bio Rad Laboratories Inc. - Key offerings
Exhibits 55: Bio Rad Laboratories Inc. - Key customers
Exhibits 56: Bio Rad Laboratories Inc. - Segment focus
Exhibits 57: biosurfit SA - Overview
Exhibits 58: biosurfit SA - Product and service
Exhibits 59: biosurfit SA - Key offerings
Exhibits 60: biosurfit SA - Key customers
Exhibits 61: biosurfit SA - Segment focus
Exhibits 62: Cardinal Health Inc. - Overview
Exhibits 63: Cardinal Health Inc. - Business segments
Exhibits 64: Cardinal Health Inc. - Key offerings
Exhibits 65: Cardinal Health Inc. - Key customers
Exhibits 66: Cardinal Health Inc. - Segment focus
Exhibits 67: Danaher Corp. - Overview
Exhibits 68: Danaher Corp. - Business segments
Exhibits 69: Danaher Corp. - Key offerings
Exhibits 70: Danaher Corp. - Key customers
Exhibits 71: Danaher Corp. - Segment focus
Exhibits 72: DIAGAST SAS - Overview
Exhibits 73: DIAGAST SAS - Product and service
Exhibits 74: DIAGAST SAS - Key offerings
Exhibits 75: DIAGAST SAS - Key customers
Exhibits 76: DIAGAST SAS - Segment focus
Exhibits 77: Grifols SA - Overview
Exhibits 78: Grifols SA - Business segments
Exhibits 79: Grifols SA - Key offerings
Exhibits 80: Grifols SA - Key customers
Exhibits 81: Grifols SA - Segment focus
Exhibits 82: Immucor Inc. - Overview
Exhibits 83: Immucor Inc. - Product and service
Exhibits 84: Immucor Inc. - Key offerings
Exhibits 85: Immucor Inc. - Key customers
Exhibits 86: Immucor Inc. - Segment focus
Exhibits 87: Merck KGaA - Overview
Exhibits 88: Merck KGaA - Business segments
Exhibits 89: Merck KGaA - Key offerings
Exhibits 90: Merck KGaA - Key customers
Exhibits 91: Merck KGaA - Segment focus
Exhibits 92: The Carlyle Group Inc. - Overview
Exhibits 93: The Carlyle Group Inc. - Business segments
Exhibits 94: The Carlyle Group Inc. - Key offerings
Exhibits 95: The Carlyle Group Inc. - Key customers
Exhibits 96: The Carlyle Group Inc. - Segment focus
Exhibits 97: Currency conversion rates for US$
Exhibits 98: Research Methodology
Exhibits 99: Validation techniques employed for market sizing
Exhibits 100: Information sources
Exhibits 101: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global immunohematology market: Becton Dickinson and Co., Bio Rad Laboratories Inc., biosurfit SA, Cardinal Health Inc., Danaher Corp., DIAGAST SAS, Grifols SA, Immucor Inc., Merck KGaA, and The Carlyle Group Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing sales through service-oriented sales organizations and GPOs.`

According to the report, one of the major drivers for this market is the growing demand for blood banks and its potential to increase sales.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.